Panagora Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History

Panagora Asset Management’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.7M	Buy	777,615 +261,689	+51%	+$4.01M	0.05%	270
2026 Q1	$7.16M	Buy	515,926 +351,189	+213%	+$5.6M	0.03%	350
2025 Q4	$2.68M	Buy	164,737 +1,945	+1%	+$31.7K	0.01%	503
2025 Q3	$2.44M	Buy	162,792 +4,216	+3%	+$51.4K	0.01%	480
2025 Q2	$1.85M	Buy	+158,576	New	+$1.44M	0.01%	493
2021 Q4	–	Sell	-9,840	Closed	-$334K	–	1533
2021 Q3	$334K	Buy	9,840 +6,703	+214%	+$242K	﹤0.01%	1476
2021 Q2	$128K	Buy	3,137 +340	+12%	+$13.2K	﹤0.01%	1800
2021 Q1	$113K	Buy	+2,797	New	+$151K	﹤0.01%	1946
2020 Q3	–	Sell	-14,759	Closed	-$714K	–	2693
2020 Q2	$714K	Buy	+14,759	New	+$538K	﹤0.01%	1058

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Panagora Asset Management's ADPT Position: Q2 2026 in Review

Panagora Asset Management increased its Adaptive Biotechnologies (ADPT) stake by 51% in Q2 2026, buying an estimated $4.01M and bringing the position to 777,615 shares worth $16.7M. The position accounts for 0.05% of the portfolio, ranked #270.

Panagora Asset Management first reported a position in ADPT in Q2 2020 and has held it in 9 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Panagora Asset Management held 777,615 shares of Adaptive Biotechnologies worth $16.7M as of Q2 2026.
Panagora Asset Management bought 261,689 Adaptive Biotechnologies shares in Q2 2026, an estimated $4.01M.
Adaptive Biotechnologies made up 0.05% of Panagora Asset Management's portfolio in Q2 2026, its #270 holding.
Panagora Asset Management first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 9 quarters since.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.